tradmap

RGEN Financials Repligen Corp

15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →

Growth & profitability

  • Revenue has grown 15.0% per year over the past 5 years.
  • Net income has grown slower than revenue (-4.0% vs 15.0% per year).
  • Operating margin has contracted, at 7.5% in the latest year.
  • Free cash flow has grown 18.5% per year over the past 5 years.

Financial health

  • The company holds more cash ($566M) than total debt ($542M).
  • Total debt has grown slower than revenue (3.2% vs 15.0% per year).
  • Operating income covered interest expense 2.6× in the latest year.
  • Total debt is 4.0× EBITDA.
Revenue & net income
-$26M $388M $802M $0 2011 2013 2015 2017 2019 2021 2023 2025
RevenueNet income
Margins (gross / operating / net)
-6% 26% 58% 0% 2011 2013 2015 2017 2019 2021 2023 2025
GrossOperatingNet
Free cash flow (CFO − capex)
$0 $75M $150M 2011 2013 2015 2017 2019 2021 2023 2025
Free cash flow
Cash vs total debt
$0 $379M $757M 2011 2013 2015 2017 2019 2021 2023 2025
CashTotal debt
Cash flow: operating / investing / financing
-$298M $93M $485M $0 2011 2013 2015 2017 2019 2021 2023 2025
OperatingInvestingFinancing

Key annual figures

FYRevenueNet incomeGross MOp MFCFTotal debtCash
2025 $738M $49M 52.3% 7.5% $94M $542M $566M
2024 $634M -$26M 43.3% -5.5% $150M $526M $757M
2023 $632M $36M 44.0% 7.5% $78M — $751M
2022 $802M $186M 56.9% 28.0% $87M — $523M
2021 $671M $128M 58.3% 24.9% $52M — $604M
2020 $366M $60M 57.2% 19.1% $40M — $717M
2019 $270M $21M 55.9% 13.4% $49M — $528M
2018 $194M $17M 55.4% 13.4% $22M — $194M
2017 $141M $28M 52.5% 9.9% $12M — $174M
2016 $105M $12M 54.9% 15.3% $3M — $122M
2015 — $9M — — — — $54M
2014 — $8M — — — — $35M
2013 — $16M — — $21M — $40M
2012 — $14M — — $12M — $29M
2011 — -$2M — — — — $11M

Valuation over time

How the market has priced RGEN against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.

Price / earnings (P/E)
0.0 153.8 307.6 Mar '23 Aug '23 Jan '24 Jun '24 Nov '24 Apr '25 Sep '25 Feb '26
P/E
Price / sales (P/S)
0.0 8.7 17.3 Mar '23 Aug '23 Jan '24 Jun '24 Nov '24 Apr '25 Sep '25 Feb '26
P/S

Frequently asked questions

Is RGEN growing its revenue and profit?

Over the past 5 years, Repligen Corp's revenue has grown 15.0% per year, and net income declined 4.0% per year. These are computed facts, not advice.

How much debt does RGEN have?

As of FY2025, Repligen Corp reported $542M of total debt against $566M of cash; operating income covered interest expense 2.6×.

What is RGEN's profit margin?

In FY2025, gross margin was 52.3%, operating margin 7.5%, and net margin 6.6%.

What is RGEN's P/E ratio?

As of Jun '26, Repligen Corp traded at a price-to-earnings ratio of about 167.7× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S have moved with the share price. These are computed facts, not advice.

Where does this data come from?

All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.

Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.